Genitourinary Syndrome of MenopauseNCT06605742
The Effect of Counseling Based on the Roy Adaptation Model on Sexual Life and Quality of Life in Menopause
A study testing Consultancy in people with Genitourinary Syndrome of Menopause and Female, run by Istanbul University at 1 site in Turkey (Türkiye).
Trial summary
In this study, it was aimed to determine the effect of the support and counseling program based on the Roy Adaptation Model given to postmenopausal women with Genitourinary Syndrome on their sexual life and quality of life. Read more about this study
- Who is it for?
- Ages 40 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Genitourinary Syndrome of Menopause, Female, Postmenopause
- What is being tested?
- Consultancy
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 92 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Nov 2021to 30 Nov 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Those between the ages of 40-60
- Verbal communication established
- Having an active sex life
- No menstruation for at least 1 year
- It has been determined that she has entered menopause with the hormone value in the blood (FSH above 25).
- Women who agree to participate in the study will be included in the sample group.
Who cannot join
- Those with advanced prolapse
- Those with Urinary Incontinence
- Those with systemic HRT
- Those who have neurological or psychiatric disorders, use antidepressants and derivatives
- Women who do not agree to participate in the research will be excluded from the study.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
İstanbul University-Cerrrahpaşa
Istanbul, 34381
About this study
Official title: The Effectiveness of The Support and Counseling Program Based on the Roy Adaptation Model in Postmenopausal Women With Genitourinary Syndrome
In this study, it was aimed to determine the effect of the support and counseling program based on the Roy Adaptation Model given to postmenopausal women with Genitourinary Syndrome on their sexual life and quality of life.
Read the detailed description
Menopause, one of the important stages of a woman's life, is a gradual physiological change process that occurs simultaneously with age and developmental changes. According to the 2018 data of the Turkish Statistical Institute (TUIK), the average life expectancy for women is 80.7 years. With the prolongation of life expectancy, the number of women in the menopause period increases and women spend 1/3 of their lives in the menopause period. By 2030, the global population of menopausal women is expected to include 1.2 billion people. Menopause, which has an important place in a woman's life, has become one of the important women's health problems that should be considered in health service planning and delivery.
Menopause is defined as the permanent cessation of menstruation due to the absence of estrogen production from the ovaries. Estrogen deprivation that occurs during this period causes the emergence of various signs and symptoms that have a significant impact on quality of life, physical, mental and sexual health. As a result of hormonal deprivation and aging, the anatomy and function of the urogenital tissues are significantly affected and vulvovaginal atrophy may occur. The terms vulvovaginal atrophy and atrophic vaginitis were found to be insufficient to describe menopausal symptoms associated with changes in the vulva, vagina, and lower urinary tract due to estrogen deficiency, and the term "Genitourinary Syndrome in Menopause (MGS)" was developed for a more inclusive terminology.
MGS is defined as the sum of symptoms and signs associated with a decrease in estrogen and other sex steroids, including changes in the labia major/minor, clitoris, vestibule, vagina, urethra, and bladder. The prevalence of MGS is 70% and causes vaginal dryness, irritation/burning/itching in the vulva or vagina, decreased lubrication during sexual activity, dyspareunia, postcoidal bleeding, frequent urination, and urinary incontinence. Srisukho et al. (2019) conducted among Thai postmenopausal women, the most common symptoms were found to be nocturia (77.7%) and vaginal dryness (51.7%). Moral et al. (2018) found that postmenopausal women most commonly experience vaginal dryness (93.3%) and decreased lubrication in sexual activity (90.0%). Selvi et al. (2020) similarly found that postmenopausal women most commonly experienced vaginal dryness (66.2%), decreased lubrication (55.3%), urgency (54.8%) and urinary incontinence 39.2%. Although these complaints negatively affect the daily life activities, quality of life and sexual health of postmenopausal women, women do not share their complaints with health care providers and often believe that they are a natural part of aging. Only 6-7% of postmenopausal women are treated. MGS associated with menopause and aging is usually permanent, unlike menopausal symptoms that disappear from time to time, such as hot flashes, but most women have no knowledge of the causes and effects of this condition. In the Vaginal Health: Perceptions, Perceptions, and Attitudes (VIVA) survey, 55% of women with vaginal conditions reported experiencing symptoms for 3 years or more, and only a minority (4%) attributed their symptoms to MGS. Age, attitudes towards menopause, sexual activity, chronic diseases, biopsychosocial reasons affect the level of MGS-related problems and the rate of seeking treatment. Chua et al. (2017) in a study conducted in five European countries, the rate of referral to healthcare professionals with the complaint of MGS was found to be in Asia (25%), the United States (56%), and Europe (62%). MGS is an under-recognized medical problem by healthcare providers and under-reported by women. Therefore, recent research suggests that healthcare providers should be proactive in helping their patients explain symptoms related to MGS. Most women expect their healthcare providers to initiate conversations about MGS complaints. Several studies of women with self-reported, MGS symptoms have shown that poor MGS management may be the result of poor awareness, reluctance to seek timely medical advice, and lack of communication between healthcare professionals.
Early recognition of signs and symptoms of MGS, provision of communication tools to facilitate dialogue, development of patient-based education programs and individual counseling are the basic steps that will help women to protect their sexual health and quality of life.While preparing the consultancy program, its preparation in accordance with the conceptual and theoretical framework will facilitate the execution and monitoring of the service. In this respect, the Roy Adaptation Model (RAM) supports the adaptation process of women with MGS complaints. According to RAM, adaptation is a set of processes in which an individual responds to environmental changes or stimuli. RAM examines stimuli in three groups as both internal and external factors. focal stimuli; are the focal stimuli that directly cause the adaptive response to which the individual immediately responds. contextual stimuli; are all other stimuli that contribute to the effect of the focal stimulus. All stimuli that are not the direct cause of the behavior, but affect the behavior and can be measured. residual stimuli; They are stimuli that can affect the individual but cannot be measured objectively. The person may not be aware of this factor or the effect of the factor may not be observed. Stimuli from the internal and external environment, in turn, activate regulatory and cognition coping mechanisms that generate behavioral responses related to physiological, self-concept, role function, and interdependence. The response of the individual occurs as a result of the stimulus and the level of adaptation. As a result, the individual exhibits adaptive behavior that maintains its integrity or ineffective, negative behavior. If a person constantly adapts, the result is health, and if the coping mechanism is insufficient, the result is disease. The goal of nursing interventions in RAM is to increase adaptive responses in each of the four adaptive domains in health and disease states. According to Roy, the four adaptive domains are independent of each other; At the same time, they have an impressive and integrating feature. A change in any of these adaptive areas causes changes in other areas. Roy Adaptation Model considers healthy and sick individuals as a whole with their physiological, psychological and social aspects. The model's use of the method of recognizing the individual in all aspects facilitates nursing interventions.
RAM is widely used as a conceptual model to guide education, research, practice and knowledge development. Elmoneim et al. (2017) found that a training program based on the Roy Adaptation Model had a positive effect on sexual function and spousal support among women with total hysterectomy. In a study conducted with a group of women in the menopausal period, it was found that the Roy Adaptation Model guides the assessment of women's adaptation levels and facilitates the management of stimuli to promote their adaptation, providing a holistic approach to evaluate and analyze the menopausal transition. In this context, it can be said that providing consultancy in accordance with the RAM model will increase the effectiveness of the consultancy service.
There are a limited number of studies on the implementation of training and consultancy for MGS in our country. As a result, the need for education and counseling is inevitable when the prevalence of MGS and the negative effects of the complaints on women's quality of life and sexual life are considered. It is thought that the counseling program based on the Roy Adaptation Model to be given to women suffering from MGS will contribute to the quality of life and sexual life of women. The educational content to be created with this study will form a direction for future studies, and the materials (booklet, etc.) to be prepared will serve as a resource for health professionals. Visibility of the problem and awareness of MGS will be provided and it will guide future researches. This study will contribute to the literature by examining the effect of the Roy Adaptation Model-based counseling program given to women with MGS complaints on their sexual life and quality of life.
- Conditions
- Genitourinary Syndrome of Menopause, Female, Postmenopause
- Being tested
- Consultancy
- Keywords
- Genitourinary Syndrome in Menopause, Roy's Adaptation Model, Sexual Health, Quality of Life
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ConsultancyOther
Also called Randomized Controlled Experimental Design
In the single-blind method, subjects do not know which of the experimental or control groups they were selected and therefore which method was applied to them.The researcher knows the subjects selected for the experimental and control groups, and therefore which method was applied to which subjects
| Study group | Role | What they receive |
|---|---|---|
| Experimental Group | Experimental | A Support and Counseling Program Based on the Roy Adaptation Model and a training booklet were prepared for women diagnosed with MGS. During the study, 5 counseling sessions were held for 4 months (16 weeks). Receives: Other: Consultancy |
| Control Grup | Experimental | Women in the control group received routine care from the hospital. They filled out the scales at the first and last interviews. At the first interview, women in the control group were given an educational booklet. Receives: Other: Consultancy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sexual functions
FSFI (Female Sexual Function Index) was used to evaluate sexual function. FSFI is a 19-item scale developed by Rosen et al. (2000) to evaluate female sexual function. Turkish validity and reliability study was conducted by Öksüz and Malhan in 2005. FSFI evaluates sexual function or problems involving the last four weeks. A minimum raw score of 4 and a maximum raw score of 95 can be obtained from the scale. After scoring by multiplying the effect coefficients determined for the sub-dimensions, the lowest score is 2 and the highest score is 36, and as the score increases, sexual functions are maintained more adequately.
Measured: 5 months
The quality of life of postmenopausal women
The Menopause Specific Quality of Life Questionnaire- MENQOL was used to assess quality of life. MENQOL is a self-administered tool developed by Hilditch et al. (1996) to assess the quality of life of menopausal women. The Turkish validity and reliability study of the scale was conducted by Kharbouch and Şahin. In MENQOL, each question item is scored between 1-8 points. A score of 1 indicates that there is no problem related to that issue, a score of 2 indicates that the issue exists but is not disturbing at all, and scores between 3-8 indicate the severity of the existing problem. A low score indicates a high quality of life in women.
Measured: 5 months
Vaginal symptoms
The International Consultation on Incontinence Questionnare-Vaginal Symptoms (ICIQVS) was used to evaluate vaginal symptoms. The ICIQ-VS scale was developed by Price et al. in 2006. Turkish validity and reliability study was conducted by Rüstemoğlu and Aslan (2021). The ICIQ-VS scale consists of 14 questions, 25 items with sub-questions, and 3 sub-dimensions (vaginal symptoms, sexual issues and quality of life).
Measured: 5 months
Depression
Beck Depression Scale was used to evaluate depression. It was developed by Beck et al. The Turkish validity and reliability study was conducted by Hisli in 1989. The BDI consists of 21 items assessing the severity of depression. The total score for the whole scale ranges from 0 to 63 points. The degree of depression is indicated by the total score
Measured: 5 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Sep 2024
- Study start1 Nov 2021
- Primary completion6 May 2022
- Study completion30 Nov 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Genitourinary Syndrome of MenopauseStudies of the same condition, open and under way.
- More trials run by Istanbul UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Controlled Experimental Design
- Masking
- None (open label)
- Enrolment
- 92 participants (actual)
Sponsor and investigators
- Lead sponsor
- Istanbul University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Arzu AKDEMİR, Uskudar University
- Investigators
- Arzu Msc Akdemir, Study director, İstanbul University-Cerrrahpaşa
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06605742
- Sponsor's protocol ID
- 9199
- Status last verified
- Aug 2024
- First submitted
- 22 May 2023
- Last updated
- 20 Sep 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Aliei MM.,Ghelichkhani F., Pakghohar M., Abadi MMM.,2016, Effectiveness of a sex education program on sexual function in postmenopausal women with sexual dysfunction: A randomized tria,In: Payesh, Vol 15, Iss 2, Pp 181-192.
Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data. Cureus. 2020 Apr 8;12(4):e7586. doi: 10.7759/cureus.7586.
PubMed 32399320ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014 Jan;123(1):202-216. doi: 10.1097/01.AOG.0000441353.20693.78.
PubMed 24463691
Study at a glance
From the registry record, last updated by the sponsor on 20 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effectiveness of The Support and Counseling Program Based on the Roy Adaptation Model in Postmenopausal Women With Genitourinary Syndrome
- ClinicalTrials.gov ID
- NCT06605742
- Acronym / sponsor ID
- 9199
- Conditions
- Genitourinary Syndrome of Menopause, Female, Postmenopause
- Keywords
- Genitourinary Syndrome in Menopause, Roy's Adaptation Model, Sexual Health, Quality of Life
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 92 participants (actual)
- Lead sponsor
- Istanbul UniversityUniversity, hospital or other
- Study start
- 1 Nov 2021 (actual)
- Primary completion
- 6 May 2022 (actual)
- Study completion
- 30 Nov 2022 (actual)
- First posted
- 20 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, it was aimed to determine the effect of the support and counseling program based on the Roy Adaptation Model given to postmenopausal women with Genitourinary Syndrome on their sexual life and quality of life.
Detailed description
Menopause, one of the important stages of a woman's life, is a gradual physiological change process that occurs simultaneously with age and developmental changes. According to the 2018 data of the Turkish Statistical Institute (TUIK), the average life expectancy for women is 80.7 years. With the prolongation of life expectancy, the number of women in the menopause period increases and women spend 1/3 of their lives in the menopause period. By 2030, the global population of menopausal women is expected to include 1.2 billion people. Menopause, which has an important place in a woman's life, has become one of the important women's health problems that should be considered in health service planning and delivery.
Menopause is defined as the permanent cessation of menstruation due to the absence of estrogen production from the ovaries. Estrogen deprivation that occurs during this period causes the emergence of various signs and symptoms that have a significant impact on quality of life, physical, mental and sexual health. As a result of hormonal deprivation and aging, the anatomy and function of the urogenital tissues are significantly affected and vulvovaginal atrophy may occur. The terms vulvovaginal atrophy and atrophic vaginitis were found to be insufficient to describe menopausal symptoms associated with changes in the vulva, vagina, and lower urinary tract due to estrogen deficiency, and the term "Genitourinary Syndrome in Menopause (MGS)" was developed for a more inclusive terminology.
MGS is defined as the sum of symptoms and signs associated with a decrease in estrogen and other sex steroids, including changes in the labia major/minor, clitoris, vestibule, vagina, urethra, and bladder. The prevalence of MGS is 70% and causes vaginal dryness, irritation/burning/itching in the vulva or vagina, decreased lubrication during sexual activity, dyspareunia, postcoidal bleeding, frequent urination, and urinary incontinence. Srisukho et al. (2019) conducted among Thai postmenopausal women, the most common symptoms were found to be nocturia (77.7%) and vaginal dryness (51.7%). Moral et al. (2018) found that postmenopausal women most commonly experience vaginal dryness (93.3%) and decreased lubrication in sexual activity (90.0%). Selvi et al. (2020) similarly found that postmenopausal women most commonly experienced vaginal dryness (66.2%), decreased lubrication (55.3%), urgency (54.8%) and urinary incontinence 39.2%. Although these complaints negatively affect the daily life activities, quality of life and sexual health of postmenopausal women, women do not share their complaints with health care providers and often believe that they are a natural part of aging. Only 6-7% of postmenopausal women are treated. MGS associated with menopause and aging is usually permanent, unlike menopausal symptoms that disappear from time to time, such as hot flashes, but most women have no knowledge of the causes and effects of this condition. In the Vaginal Health: Perceptions, Perceptions, and Attitudes (VIVA) survey, 55% of women with vaginal conditions reported experiencing symptoms for 3 years or more, and only a minority (4%) attributed their symptoms to MGS. Age, attitudes towards menopause, sexual activity, chronic diseases, biopsychosocial reasons affect the level of MGS-related problems and the rate of seeking treatment. Chua et al. (2017) in a study conducted in five European countries, the rate of referral to healthcare professionals with the complaint of MGS was found to be in Asia (25%), the United States (56%), and Europe (62%). MGS is an under-recognized medical problem by healthcare providers and under-reported by women. Therefore, recent research suggests that healthcare providers should be proactive in helping their patients explain symptoms related to MGS. Most women expect their healthcare providers to initiate conversations about MGS complaints. Several studies of women with self-reported, MGS symptoms have shown that poor MGS management may be the result of poor awareness, reluctance to seek timely medical advice, and lack of communication between healthcare professionals.
Early recognition of signs and symptoms of MGS, provision of communication tools to facilitate dialogue, development of patient-based education programs and individual counseling are the basic steps that will help women to protect their sexual health and quality of life.While preparing the consultancy program, its preparation in accordance with the conceptual and theoretical framework will facilitate the execution and monitoring of the service. In this respect, the Roy Adaptation Model (RAM) supports the adaptation process of women with MGS complaints. According to RAM, adaptation is a set of processes in which an individual responds to environmental changes or stimuli. RAM examines stimuli in three groups as both internal and external factors. focal stimuli; are the focal stimuli that directly cause the adaptive response to which the individual immediately responds. contextual stimuli; are all other stimuli that contribute to the effect of the focal stimulus. All stimuli that are not the direct cause of the behavior, but affect the behavior and can be measured. residual stimuli; They are stimuli that can affect the individual but cannot be measured objectively. The person may not be aware of this factor or the effect of the factor may not be observed. Stimuli from the internal and external environment, in turn, activate regulatory and cognition coping mechanisms that generate behavioral responses related to physiological, self-concept, role function, and interdependence. The response of the individual occurs as a result of the stimulus and the level of adaptation. As a result, the individual exhibits adaptive behavior that maintains its integrity or ineffective, negative behavior. If a person constantly adapts, the result is health, and if the coping mechanism is insufficient, the result is disease. The goal of nursing interventions in RAM is to increase adaptive responses in each of the four adaptive domains in health and disease states. According to Roy, the four adaptive domains are independent of each other; At the same time, they have an impressive and integrating feature. A change in any of these adaptive areas causes changes in other areas. Roy Adaptation Model considers healthy and sick individuals as a whole with their physiological, psychological and social aspects. The model's use of the method of recognizing the individual in all aspects facilitates nursing interventions.
RAM is widely used as a conceptual model to guide education, research, practice and knowledge development. Elmoneim et al. (2017) found that a training program based on the Roy Adaptation Model had a positive effect on sexual function and spousal support among women with total hysterectomy. In a study conducted with a group of women in the menopausal period, it was found that the Roy Adaptation Model guides the assessment of women's adaptation levels and facilitates the management of stimuli to promote their adaptation, providing a holistic approach to evaluate and analyze the menopausal transition. In this context, it can be said that providing consultancy in accordance with the RAM model will increase the effectiveness of the consultancy service.
There are a limited number of studies on the implementation of training and consultancy for MGS in our country. As a result, the need for education and counseling is inevitable when the prevalence of MGS and the negative effects of the complaints on women's quality of life and sexual life are considered. It is thought that the counseling program based on the Roy Adaptation Model to be given to women suffering from MGS will contribute to the quality of life and sexual life of women. The educational content to be created with this study will form a direction for future studies, and the materials (booklet, etc.) to be prepared will serve as a resource for health professionals. Visibility of the problem and awareness of MGS will be provided and it will guide future researches. This study will contribute to the literature by examining the effect of the Roy Adaptation Model-based counseling program given to women with MGS complaints on their sexual life and quality of life.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized Controlled Experimental Design
| Arm | Type | Receives |
|---|---|---|
| Experimental Group | Experimental | Other: ConsultancyA Support and Counseling Program Based on the Roy Adaptation Model and a training booklet were prepared for women diagnosed with MGS. During the study, 5 counseling sessions were held for 4 months (16 weeks). |
| Control Grup | Experimental | Other: ConsultancyWomen in the control group received routine care from the hospital. They filled out the scales at the first and last interviews. At the first interview, women in the control group were given an educational booklet. |
Who may qualify
- Ages
- 40 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (6 listed)
- Those between the ages of 40-60
- Verbal communication established
- Having an active sex life
- No menstruation for at least 1 year
- It has been determined that she has entered menopause with the hormone value in the blood (FSH above 25).
Key exclusion criteria (5 listed)
- Those with advanced prolapse
- Those with Urinary Incontinence
- Those with systemic HRT
- Those who have neurological or psychiatric disorders, use antidepressants and derivatives
- Women who do not agree to participate in the research will be excluded from the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ConsultancyAlso: Randomized Controlled Experimental DesignIn the single-blind method, subjects do not know which of the experimental or control groups they were selected and therefore which method was applied to them.The researcher knows the subjects selected for the experimental and control groups, and therefore which method was applied to which subjects | Other | Control Grup, Experimental Group |
Primary outcome
Sexual functions
Time frame: 5 months
FSFI (Female Sexual Function Index) was used to evaluate sexual function. FSFI is a 19-item scale developed by Rosen et al. (2000) to evaluate female sexual function. Turkish validity and reliability study was conducted by Öksüz and Malhan in 2005. FSFI evaluates sexual function or problems involving the last four weeks. A minimum raw score of 4 and a maximum raw score of 95 can be obtained from the scale. After scoring by multiplying the effect coefficients determined for the sub-dimensions, the lowest score is 2 and the highest score is 36, and as the score increases, sexual functions are maintained more adequately.
The quality of life of postmenopausal women
Time frame: 5 months
The Menopause Specific Quality of Life Questionnaire- MENQOL was used to assess quality of life. MENQOL is a self-administered tool developed by Hilditch et al. (1996) to assess the quality of life of menopausal women. The Turkish validity and reliability study of the scale was conducted by Kharbouch and Şahin. In MENQOL, each question item is scored between 1-8 points. A score of 1 indicates that there is no problem related to that issue, a score of 2 indicates that the issue exists but is not disturbing at all, and scores between 3-8 indicate the severity of the existing problem. A low score indicates a high quality of life in women.
Vaginal symptoms
Time frame: 5 months
The International Consultation on Incontinence Questionnare-Vaginal Symptoms (ICIQVS) was used to evaluate vaginal symptoms. The ICIQ-VS scale was developed by Price et al. in 2006. Turkish validity and reliability study was conducted by Rüstemoğlu and Aslan (2021). The ICIQ-VS scale consists of 14 questions, 25 items with sub-questions, and 3 sub-dimensions (vaginal symptoms, sexual issues and quality of life).
Depression
Time frame: 5 months
Beck Depression Scale was used to evaluate depression. It was developed by Beck et al. The Turkish validity and reliability study was conducted by Hisli in 1989. The BDI consists of 21 items assessing the severity of depression. The total score for the whole scale ranges from 0 to 63 points. The degree of depression is indicated by the total score
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 Sep 2024.
- BackgroundAliei MM.,Ghelichkhani F., Pakghohar M., Abadi MMM.,2016, Effectiveness of a sex education program on sexual function in postmenopausal women with sexual dysfunction: A randomized tria,In: Payesh, Vol 15, Iss 2, Pp 181-192.
- Background: PubMed 32399320Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data. Cureus. 2020 Apr 8;12(4):e7586. doi: 10.7759/cureus.7586.
- Background: PubMed 24463691ACOG Practice Bulletin No. 141: management of menopausal symptoms. Obstet Gynecol. 2014 Jan;123(1):202-216. doi: 10.1097/01.AOG.0000441353.20693.78.
Related trials for Genitourinary Syndrome of Menopause
Active, not recruiting
Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study
Cardiovascular Diseases
RecruitingObservational study
Predictors of Religious Orientation Attitudes in Menopausal Women
Menopause, Menopausal Syndrome
Not yet recruitingObservational study
Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause.
Vulvar Atrophy, Vulvovaginal Signs and Symptoms
Not yet recruitingPhase 4
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
Menopausal Complaints, Vaginal Atrophy
Not yet recruiting
Photobiomodulation for Vaginal Dysfunctions: Home-Based vs Outpatient Treatment
Genitourinary Syndrome of Menopause (GSM), Bacterial Vaginosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Arzu Msc Akdemir study director
İstanbul University-Cerrrahpaşa
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Consultancy in people with Genitourinary Syndrome of Menopause and Female, run by Istanbul University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 20 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sexual functions (time frame: 5 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06605742, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Sep 2024.